Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ New Found Gold doubles Queensway valuation to $1.2B (Mining.com) +++ NEW FOUND GOLD Aktie +5,01%

PBR Nachrichten

PBR (Pharmaceutical Business Review) ist ein Onlineportal mit News zur Pharma- und Biotechnologiebranche. Die Redaktion berichtet über neue Medikamente und deren Zulassungsverfahren, sowie über geschäftliche Entwicklungen von Pharmaunternehmen.
 
23.10.26 - 12:00
Celltrion and Kaigene sign $580m licence deal for KG013 (PBR)
 
The financial package includes an upfront payment alongside milestone payments tied to specific development, regulatory, and commercial targets. Royalties on net sales remain separate from the package. Kaigene The post Celltrion and Kaigene sign $580m licence deal for KG013 appeared first on Pharmaceutical Business review....
22.10.26 - 15:00
تحميل وان اكس بت: دليل الأمان الكامل للعب آمن في الإمارات (PBR)
 
ما هو تطبيق وان اكس بت وكيف يعمل؟ خطوات تحميل وان اكس بت على الهواتف الذكية المتطلبات التقنية قبل التحميل طريقة التحميل عبر المتصفح أو المتجر التسجيل وإنشاء The post تحميل وان اكس بت: دليل الأمان الكامل للعب آمن في الإمارات appeared first on Pharmaceutical Business review....
22.10.26 - 15:00
تنزيل وان اكس بت مصر: خطوات التسجيل وتحميل التطبيق خطوة بخطوة (PBR)
 
دليل شامل لتنزيل وان اكس بت مصر: كل ما تحتاج معرفته مقدمة حول تنزيل وان اكس بت مصر يبحث الكثير من عشاق القمار على الإنترنت عن طريقة سريعة The post تنزيل وان اكس بت مصر: خطوات التسجيل وتحميل التطبيق خطوة بخطوة appeared first on Pharmaceutical Business review....
22.10.26 - 15:00
1xbet app – what you need to know (PBR)
 
Getting Started – Registration and First Steps Verifying Your Identity (KYC) Navigating the 1xbet App – Interface and Core Features Sportsbook vs Live Casino Mobile Experience Tips Bonuses The post 1xbet app – what you need to know appeared first on Pharmaceutical Business review....
22.10.26 - 12:12
Astellas and AI Proteins sign miniprotein therapeutics deal (PBR)
 
Under the deal, AI Proteins is set to receive an upfront cash sum of more than $400m to design and optimise de novo miniproteins directed at targets selected The post Astellas and AI Proteins sign miniprotein therapeutics deal appeared first on Pharmaceutical Business review....
22.10.26 - 11:48
MSD′s Keytruda and Padcev combination receives EC approval (PBR)
 
The clearance permits the therapies to be administered before radical cystectomy as neoadjuvant therapy and continued following surgery as adjuvant treatment. Applicable to patients irrespective of cisplatin eligibility, The post MSD's Keytruda and Padcev combination receives EC approval appeared first on Pharmaceutical Business review....
22.10.26 - 03:36
1win App Registration Download Bonus Guide (PBR)
 
Why Choose the 1win Mobile App? How to Perform the 1win App Registration Download Safely 1win App Registration Download: Step‑by‑Step Account Creation Verification (KYC) – Making Your 1win The post 1win App Registration Download Bonus Guide appeared first on Pharmaceutical Business review....
22.10.26 - 03:36
1win Global App Mobile Guide – Registration, Play & Cash Out (PBR)
 
Practical Guide to the 1win Global App – How to Register, Play, and Cash Out Getting Started: Registration and First Steps When you open the 1win global app The post 1win Global App Mobile Guide – Registration, Play & Cash Out appeared first on Pharmaceutical Business review....
21.10.26 - 12:24
FDA approves Cosette′s Evoxac oral solution for Sjögren′s disease (PBR)
 
The regulatory decision represents the first new drug application (NDA) approval secured by the speciality pharmaceutical manufacturer. Cosette expects the therapy to be commercially accessible in the US The post FDA approves Cosette's Evoxac oral solution for Sjögren's disease appeared first on Pharmaceutical Business review....
21.10.26 - 12:12
Sanofi and ScionxBio partner on mRNA therapies (PBR)
 
Under the arrangement, the companies will create extended-exposure formulations of selected mRNA candidates from Sanofi by applying ScionxBio's TERA technology. The partnership divides research and clinical duties between The post Sanofi and ScionxBio partner on mRNA therapies appeared first on Pharmaceutical Business review....
19.10.26 - 12:36
FDA approves Viatris′ Ryzumvi for adult presbyopia (PBR)
 
In the US, Ryzumvi is already marketed as the sole authorised treatment for pharmacologically-induced mydriasis. Under a global licensing agreement with Opus Genetics, Viatris holds exclusive rights to The post FDA approves Viatris' Ryzumvi for adult presbyopia appeared first on Pharmaceutical Business review....
19.10.26 - 11:36
Estuary secures $103m to advance kidney disease gene therapies (PBR)
 
The capital will fund clinical proof-of-concept testing for the biotechnology company's lead gene therapy candidates, EST-101 and EST-201, whilst advancing its platform for direct kidney delivery. The total The post Estuary secures $103m to advance kidney disease gene therapies appeared first on Pharmaceutical Business review....
16.10.26 - 12:36
Acta Pharmaceuticals raises $24m for Alzheimer′s therapies (PBR)
 
It is a gamma-secretase modulator being developed as a potent once-daily oral therapy for the treatment and potential prevention of AD. According to the company, existing therapies approved The post Acta Pharmaceuticals raises $24m for Alzheimer's therapies appeared first on Pharmaceutical Business review....
16.10.26 - 11:48
Transcripta Bio, Mayo Clinic join force on ALS therapies (PBR)
 
The initiative centres on creating a high-resolution, patient-derived molecular map of the fatal neurodegenerative disorder, which currently has few effective therapies. Under the terms of the agreement, Mayo The post Transcripta Bio, Mayo Clinic join force on ALS therapies appeared first on Pharmaceutical Business review....
15.10.26 - 12:36
QCi and INmune Bio partner to study XPro in Alzheimer′s (PBR)
 
The initial agreement marks the first commercial contract in the pharmaceutical and biotechnology sector for QCi. Under the first stage of the project, the companies will analyse clinical The post QCi and INmune Bio partner to study XPro in Alzheimer's appeared first on Pharmaceutical Business review....
15.10.26 - 12:12
Alentis and PinotBio partner to develop claudin-1 oncology ADCs (PBR)
 
Under the agreement, Alentis has secured an exclusive option to in-license linkers and payloads from PinotBio for use in its pipeline candidates. Financially, PinotBio will receive an upfront The post Alentis and PinotBio partner to develop claudin-1 oncology ADCs appeared first on Pharmaceutical Business review....
14.10.26 - 12:24
Charles River partners with Magellan Stem Cells on cell therapy (PBR)
 
The partnership focuses on biologics quality control as well as viral and release testing under current good manufacturing practice (cGMP) standards. Magellan recently completed Phase I/II clinical studies The post Charles River partners with Magellan Stem Cells on cell therapy appeared first on Pharmaceutical Business review....
14.10.26 - 12:00
Pfizer partners with Enodia Therapeutics in $500m drug deal (PBR)
 
Under the partnership, Enodia Therapeutics will handle initial discovery work to identify, refine, and advance small-molecule candidates directed at multiple targets. Pfizer will take full responsibility for subsequent The post Pfizer partners with Enodia Therapeutics in $500m drug deal appeared first on Pharmaceutical Business review....
13.10.26 - 12:01
China′s NMPA clears Foresee′s Camcevi 42 mg for prostate cancer (PBR)
 
The company was informed of the decision by its domestic licensing partner, Changchun GeneScience Pharmaceutical (GenSci). GenSci holds exclusive Chinese commercial rights to Camcevi across all existing and The post China's NMPA clears Foresee's Camcevi 42 mg for prostate cancer appeared first on Pharmaceutical Business review....
13.10.26 - 12:01
Southern Research secures NIH funding for drug testing hub (PBR)
 
The planned facility will focus on the development, validation, and adoption of new approach methodologies (NAMs). These laboratory, computational, and data-oriented methods are designed to mirror human biology The post Southern Research secures NIH funding for drug testing hub appeared first on Pharmaceutical Business review....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Sünden werden vergeben, aber die Strafe folgt nach. - Sprichwort Deutschland
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!